BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10731971)

  • 1. [Ethyol (amifostine): application trial in pediatric oncology].
    Korzon M; Popadiuk S; Plata-Nazar K; Gołebiewski J; Szarszewski A; Czauderna P; Stoba C
    Wiad Lek; 1998; 51 Suppl 4():215-9. PubMed ID: 10731971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I trial of amifostine (WR-2721) and melphalan in children with refractory cancer.
    Adamson PC; Balis FM; Belasco JE; Lange B; Berg SL; Blaney SM; Craig C; Poplack DG
    Cancer Res; 1995 Sep; 55(18):4069-72. PubMed ID: 7664282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B; Bode U; von Schweinitz D
    Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoprotective effects of amifostine in the treatment of childhood malignancies.
    Cetingül N; Midyat L; Kantar M; Demirağ B; Aksoylar S; Kansoy S
    Pediatr Blood Cancer; 2009 Jul; 52(7):829-33. PubMed ID: 19214974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amifostine (Ethyol) as modulator of hepatic and biliary toxicity from intraarterial hepatic chemoembolization: results of a phase I study.
    Fiorentini G; Giovanis P; Leoni M; De Giorgi U; Cariello A; Dazzi C; Caldeo A
    Hepatogastroenterology; 2001; 48(38):313-6. PubMed ID: 11379297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of amifostine on reducing acute toxicity of megachemotherapy of tumors in children].
    Válková J; Stanková J; Kavan P; Kabícková E; Gajdos P; Koutecký J
    Cas Lek Cesk; 2002 May; 141(10):316-9. PubMed ID: 12078585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
    Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplantation.
    Hartmann JT; von Vangerow A; Fels LM; Knop S; Stolte H; Kanz L; Bokemeyer C
    Br J Cancer; 2001 Feb; 84(3):313-20. PubMed ID: 11161394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amifostine before chemotherapy: improved tolerance profile of the subcutaneous over the intravenous route.
    Koukourakis MI; Simopoulos C; Minopoulos G; Patlakas G; Polychronidis A; Limberis V; Romanides K; Pitiacoudis M; Manolas C
    Clin Cancer Res; 2003 Aug; 9(9):3288-93. PubMed ID: 12960114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children's Oncology Group study.
    Marina N; Chang KW; Malogolowkin M; London WB; Frazier AL; Womer RB; Rescorla F; Billmire DF; Davis MM; Perlman EJ; Giller R; Lauer SJ; Olson TA;
    Cancer; 2005 Aug; 104(4):841-7. PubMed ID: 15999362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytoprotective effect of amifostine in children during induction therapy according to BFM-83: report on cases].
    Nowak K; Bolanowski W; Zalewska-Szewczyk B; Stolarska M; Bodalski J
    Wiad Lek; 1998; 51 Suppl 4():220-6. PubMed ID: 10731972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of amifostine on toxicities associated with salvage combination chemotherapy.
    Awasthy BS; Julka PK; Agarwal S; Nair O; Bhamrah R; Rath GK
    J Assoc Physicians India; 2001 Feb; 49():236-9. PubMed ID: 11225137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Renal protection with amifostine during intraoperative peritoneal chemohyperthermia (IPCH) with cisplatin (CDDP) for peritoneal carcinosis. Phase 1 study].
    Vaira M; Barone R; Aghemo B; Mioli PR; De Simone M
    Minerva Med; 2001 Aug; 92(4):207-11. PubMed ID: 11535965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer.
    Machtay M; Rosenthal DI; Chalian AA; Lustig R; Hershock D; Miller L; Weinstein GS; Weber RS
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):72-7. PubMed ID: 15093901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amifostine as chemoprotectant in metastatic breast cancer patients treated with doxorubicin.
    Catino A; Crucitta E; Latorre A; Sambiasi D; Calabrese P; Lorusso V
    Oncol Rep; 2003; 10(1):163-7. PubMed ID: 12469164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection by amifostine of cyclophosphamide-induced myelosuppression.
    Alberts DS
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):37-40. PubMed ID: 10348259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity prevention with amifostine in pediatric osteosarcoma patients treated with cisplatin and doxorubicin.
    Gallegos-Castorena S; Martínez-Avalos A; Mohar-Betancourt A; Guerrero-Avendaño G; Zapata-Tarrés M; Medina-Sansón A
    Pediatr Hematol Oncol; 2007 Sep; 24(6):403-8. PubMed ID: 17710657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma of the head and neck.
    Law A; Kennedy T; Pellitteri P; Wood C; Christie D; Yumen O
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1361-8. PubMed ID: 17869022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined treatment of stage IV melanoma patients with amifostine and fotemustine--a pilot study.
    Mohr P; Makki A; Breitbart E; Schadendorf D
    Melanoma Res; 1998 Apr; 8(2):166-9. PubMed ID: 9610871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.